Terug
18
Dagbereik
€ 295,90
€ 305,39
52-Weeksbereik
€ 275,05
€ 414,15
Volume
507.303
50D / 200D Gem.
€ 344,13
/
€ 339,49
Vorige Slotkoers
€ 301,81
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 28,0 | 0,3 |
| P/B | 7,0 | 2,9 |
| ROE % | 29,3 | 3,7 |
| Net Margin % | 20,3 | 3,8 |
| Rev Growth 5Y % | 3,2 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 401,00
+32.8%
Low: € 350,00
High: € 480,00
Forward K/W
21,0
Forward WPA
€ 14,38
WPA Groei (sch.)
+0,0%
Omzet Sch.
6,4 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 21,59
€ 21,03 – € 21,98
|
8,3 B | 1 |
| FY2029 |
€ 20,27
€ 19,75 – € 20,63
|
8 B | 1 |
| FY2028 |
€ 17,87
€ 16,68 – € 19,62
|
7,5 B | 3 |
Belangrijkste Punten
Revenue grew 3,24% annually over 5 years — modest growth
ROE of 29,28% indicates high profitability
Net margin of 20,30% shows strong profitability
Generating 539,81M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,75%
Cash machine — converts 84,00% of earnings into free cash flow
Groei
Revenue Growth (5Y)
3,24%
Revenue (1Y)6,99%
Earnings (1Y)0,75%
FCF Growth (3Y)10,49%
Kwaliteit
Return on Equity
29,28%
ROIC16,88%
Net Margin20,30%
Op. Margin28,22%
Veiligheid
Debt / Equity
0,55
Current RatioN/A
Interest Coverage17,59
Waardering
P/E Ratio
27,96
P/B Ratio7,01
EV/EBITDA21,03
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,99% | Revenue Growth (3Y) | 3,47% |
| Earnings Growth (1Y) | 0,75% | Earnings Growth (3Y) | 0,03% |
| Revenue Growth (5Y) | 3,24% | Earnings Growth (5Y) | -1,86% |
| Profitability | |||
| Revenue (TTM) | 3,17B | Net Income (TTM) | 642,63M |
| ROE | 29,28% | ROA | 12,64% |
| Gross Margin | 57,77% | Operating Margin | 28,22% |
| Net Margin | 20,30% | Free Cash Flow (TTM) | 539,81M |
| ROIC | 16,88% | FCF Growth (3Y) | 10,49% |
| Safety | |||
| Debt / Equity | 0,55 | Current Ratio | N/A |
| Interest Coverage | 17,59 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 27,96 | P/B Ratio | 7,01 |
| P/S Ratio | 5,68 | PEG Ratio | 75,62 |
| EV/EBITDA | 21,03 | Dividend Yield | 0,00% |
| Market Cap | 17,97B | Enterprise Value | 18,79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,17B | 2,96B | 2,96B | 2,97B | 2,79B |
| Net Income | 642,63M | 637,83M | 642,23M | 707,76M | 692,84M |
| EPS (Diluted) | 10,76 | 10,71 | 10,84 | 11,73 | 11,17 |
| Gross Profit | 1,83B | 1,76B | 1,76B | 1,72B | 1,63B |
| Operating Income | 893,22M | 826,35M | 817,68M | 873,40M | 821,71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,08B | 4,55B | 4,63B | 3,28B | 3,09B |
| Total Liabilities | 2,52B | 2,73B | 3,48B | 2,78B | 2,73B |
| Shareholders' Equity | 2,56B | 1,83B | 1,15B | 504,49M | 367,55M |
| Total Debt | 1,41B | 1,70B | 2,44B | 1,66B | 1,60B |
| Cash & Equivalents | 587,83M | 324,42M | 395,08M | 480,53M | 501,23M |
| Current Assets | 1,99B | 1,67B | 1,75B | 1,76B | 1,63B |
| Current Liabilities | 0,0 | 789,76M | 789,58M | 785,74M | 680,51M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#999 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026